These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9430645)

  • 1. p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53.
    Ori A; Zauberman A; Doitsh G; Paran N; Oren M; Shaul Y
    EMBO J; 1998 Jan; 17(2):544-53. PubMed ID: 9430645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.
    Suzuki T; Uchida-Toita M; Yoshida M
    Oncogene; 1999 Jul; 18(28):4137-43. PubMed ID: 10435595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-specific enhancer II is the target for the p53-mediated inhibition of hepatitis B viral gene expression.
    Lee H; Kim HT; Yun Y
    J Biol Chem; 1998 Jul; 273(31):19786-91. PubMed ID: 9677410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a DNA element that can enhance p53-mediated transactivation.
    Shiio Y; Yamamoto T; Yamaguchi N
    Oncogene; 1993 Aug; 8(8):2059-65. PubMed ID: 8393159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SREBP-1a activation by HBx and the effect on hepatitis B virus enhancer II/core promoter.
    Qiao L; Wu Q; Lu X; Zhou Y; Fernández-Alvarez A; Ye L; Zhang X; Han J; Casado M; Liu Q
    Biochem Biophys Res Commun; 2013 Mar; 432(4):643-9. PubMed ID: 23422505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system.
    Takada S; Kaneniwa N; Tsuchida N; Koike K
    Virology; 1996 Feb; 216(1):80-9. PubMed ID: 8615009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
    Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
    Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of p53-mediated transcription by MDM2: a dual mechanism.
    Thut CJ; Goodrich JA; Tjian R
    Genes Dev; 1997 Aug; 11(15):1974-86. PubMed ID: 9271120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Chen J; Lin J; Levine AJ
    Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene.
    Liang H; Lunec J
    Gene; 2005 Nov; 361():112-8. PubMed ID: 16202543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.
    Shamay M; Agami R; Shaul Y
    Oncogene; 2001 Oct; 20(47):6811-9. PubMed ID: 11687960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.
    Venot C; Maratrat M; Dureuil C; Conseiller E; Bracco L; Debussche L
    EMBO J; 1998 Aug; 17(16):4668-79. PubMed ID: 9707426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.
    Ku WC; Chiu SK; Chen YJ; Huang HH; Wu WG; Chen YJ
    Mol Cell Proteomics; 2009 Sep; 8(9):2034-50. PubMed ID: 19505873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a specific region in the hepatitis B virus enhancer I for the efficient expression of X gene in the hepatic cell.
    Fukai K; Takada S; Yokosuka O; Saisho H; Omata M; Koike K
    Virology; 1997 Sep; 236(2):279-87. PubMed ID: 9325235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of the hepatitis B virus enhancer by a cellular factor.
    Spandau DF; Lee CH
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():131-7. PubMed ID: 1730933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDMX: a novel p53-binding protein with some functional properties of MDM2.
    Shvarts A; Steegenga WT; Riteco N; van Laar T; Dekker P; Bazuine M; van Ham RC; van der Houven van Oordt W; Hateboer G; van der Eb AJ; Jochemsen AG
    EMBO J; 1996 Oct; 15(19):5349-57. PubMed ID: 8895579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
    Kwon JA; Rho HM
    Biol Chem; 2003 Feb; 384(2):203-12. PubMed ID: 12675512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targets for transcriptional activation by wild-type p53: endogenous retroviral LTR, immunoglobulin-like promoter, and an internal promoter of the mdm2 gene.
    Barak Y; Lupo A; Zauberman A; Juven T; Aloni-Grinstein R; Gottlieb E; Rotter V; Oren M
    Cold Spring Harb Symp Quant Biol; 1994; 59():225-35. PubMed ID: 7587074
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional characterization of the interferon regulatory element in the enhancer 1 region of the hepatitis B virus genome.
    Alcantara FF; Tang H; McLachlan A
    Nucleic Acids Res; 2002 May; 30(9):2068-75. PubMed ID: 11972347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.